The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $21,000 to Pfizer Inc., doing business as Pfizer, for the delivery of ondansetron hydrochloride injection. The contract has a period of performance from August 18-23, 2023, with all work to be conducted at Pfizer's place of performance in New York, New York. The delivery order was issued against an existing indefinite-delivery/indefinite-quantity vehicle to supply pharmaceutical products in...
<p>This delivery order for $21 of ondansetron hydrochloride (PF) 4 mg/2 ml injections was awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. on August 22, 2023, with a completion date of August 25, 2023. The firm fixed price contract was issued under an existing vehicle to supply the agency's medical programs with the requested pharmaceutical products. No set-aside designation was applied to this award. Place of performance will be Pfizer's New York City location.</p>
This federal contract award is for the delivery of 30-count packages of 4 mg Ondansetron HCl tablets to the Medical Supply Chain, a defense agency of the Department of Defense. The $3,840.87 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 28, 2024, with a completion date of August 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
This is a $1,191.01 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. The award has a performance period through March 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 100 units of 8 mg ondansetron hydrochloride tablets, valued at $1,116.45, with an ultimate completion date of April 19, 2024. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the...
The federal government awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,285,861 tablets of 8 mg ondansetron hydrochloride, a medication used to treat nausea and vomiting. The contract, valued at $16,173.65, was awarded by the Defense Logistics Agency (DLA) on July 29, 2024, with a completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,563,358,978 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $12,144.43 and an ultimate completion date of January 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supply chain services. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $75,440.91 firm fixed-price delivery order is for the supply of 500 packs of 8 mg Ondansetron HCl tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies for military healthcare...
This is a federal contract award with ID SPE2DX15D1053|SPE2DX25F6FQF to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,816,325 units of Ondansetron HCL 8 mg tablets, with a firm fixed price ceiling value of $15,898.90. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026....
The Defense Logistics Agency Troop Support Medical awarded a $10,500 delivery order to Pfizer Inc. for the supply of ondansetron hydrochloride injection. The firm fixed price order is for 4561659181 units of the 4 mg/2 ml antiemetic drug to be delivered from Pfizer's New York City location between August 1-4, 2023. As a major provider of pharmaceuticals to the Department of Defense, this award supports DLA's mission to provide quality medical supplies to troops worldwide. No subcontractors or...